Before starting any such testing, one must define the failure criteria. For pharmaceutical items, potency is usually the biggest deciding factor. As the product ages, it can lose potency to the point where it is no longer functional. When conducting the inspection of the product, it is also important to make sure the package is not compromised. A white plastic bottle can discolor or become brittle over time and may make the contents unsellable, even though the product itself is still useable. For a sealed pouch, it is possible that the seals could degrade and cause the product to lose sterility.
The failure mode must be broken down to the point where an inspection test can be designed, with a set number of planned inspections to take place throughout the aging study. The amount of material required per inspection should be multiplied by the number of planned inspections, and must all be included at the start of the aging test. At regular intervals, a sample of the product is taken out of the aging chamber and inspected agai
nst the acceptance criteria to determine if the amount of time passed constitutes a loss of product integrity. If the inspection is not destructive (such as visual inspection), the product can just be placed back into the aging environment and then reinspected at a later date. However, if the inspection testing is destructive (such as bubble leak), the product quantity used for the aging test must be enough to accommodate the additional periodic inspections without running out of material before the end of the study.
The end goal of accelerated aging is to determine the product’s usable shelf life based on scientific study, without having to wait for the real time aging to complete. While results might vary for different materials, this can shave months or even years from the product launch process.